Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole

被引:4
作者
Chirch, Lisa [1 ]
Roche, Patricia [2 ]
Fuhrer, Jack [1 ]
机构
[1] SUNY Stony Brook, Med Ctr, Div Infect Dis, Dept Internal Med,Sch Med, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Sch Med, Dept Radiol, Stony Brook, NY 11794 USA
关键词
D O I
10.1177/014556130808700110
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Chronic invasive Aspergillus sinusitis is a rare and potentially devastating infection. Management typically requires extensive surgical debridement followed by long-term antifungal therapy, primarily with intravenous amphotericin B. We describe the case of an elderly woman who bad been diagnosed with extensive Aspergillus sinusitis that had invaded critical structures. The extensiveness of the infection and the patient's family and unwillingness to undergo a disfiguring procedure precluded surgery, and her medical condition was too fragile to withstand amphotericin B therapy. Therefore, we decided to treat her with a combination of caspofungin and voriconazole, two relatively nontoxic antifungal agents that have different mechanisms of action. After administration Of this novel regimen, the infection resolved rapidly.
引用
收藏
页码:30 / 33
页数:4
相关论文
共 13 条
[1]   In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. [J].
Arikan, S ;
Lozano-Chiu, M ;
Paetznick, V ;
Rex, JH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :245-247
[2]   Invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :781-803
[3]   Definitions of fungal rhinosinusitis [J].
Ferguson, BJ .
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2000, 33 (02) :227-+
[4]   Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].
Herbrecht, R ;
Denning, DW ;
Patterson, TF ;
Bennett, JE ;
Greene, RE ;
Oestmann, JW ;
Kern, WV ;
Marr, KA ;
Ribaud, P ;
Lortholary, O ;
Sylvester, R ;
Rubin, RH ;
Wingard, JR ;
Stark, P ;
Durand, C ;
Caillot, D ;
Thiel, E ;
Chandrasekar, PH ;
Hodges, MR ;
Schlamm, HT ;
Troke, PF ;
de Pauw, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415
[5]   Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis [J].
Kirkpatrick, WR ;
Perea, S ;
Coco, BJ ;
Patterson, TF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2564-2568
[6]   Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis [J].
Maertens, Johan ;
Glasmacher, Axel ;
Herbrecht, Raoul ;
Thiebaut, Anne ;
Cordonnier, Catherine ;
Segal, Brahm H. ;
Killar, John ;
Taylor, Arlene ;
Kartsonis, Nicholas ;
Patterson, Thomas F. .
CANCER, 2006, 107 (12) :2888-2897
[7]   Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus [J].
Manavathu, EK ;
Alangaden, GJ ;
Chandrasekar, PH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (06) :1423-1425
[8]   Combination antifungal therapy for invasive aspergillosis [J].
Marr, KA ;
Boeckh, M ;
Carter, RA ;
Kim, HW ;
Corey, L .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) :797-802
[9]   In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. [J].
Perea, S ;
Gonzalez, G ;
Fothergill, AW ;
Kirkpatrick, WR ;
Rinaldi, MG ;
Patterson, TF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :3039-3041
[10]   Combination therapy in treatment of experimental pulmonary aspergillosis: Synergistic interaction between an antifungal triazole and an echinocandin [J].
Petraitis, V ;
Petraitiene, R ;
Sarafandi, AA ;
Keleher, AM ;
Lyman, CA ;
Casler, HE ;
Sein, T ;
Groll, AH ;
Becher, J ;
Avila, NA ;
Walsh, TJ .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (12) :1834-1843